MORRISVILLE, N.Y. (AP) — MORRISVILLE, N.Y. (AP) — TG Therapeutics Inc. (TGTX) on Wednesday reported a loss of $10.7 million in its first quarter.
On a per-share basis, the Morrisville, New York-based company said it had a loss of 7 cents.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 3 cents per share.
The biopharmaceutical company posted revenue of $63.5 million in the period, topping Street forecasts. Four analysts surveyed by Zacks expected $54.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TGTX at https://www.zacks.com/ap/TGTX
For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights.
, source Associated Press News